2031년까지의 중동과 아프리카 동물 및 인간 백신 시장 규모 분석

중동 및 아프리카 동물 및 인간 백신 시장, 유형(인간 및 동물), 최종 사용자(병원, 진료소 및 기타), 유통 채널(직접 입찰, 소매 판매 및 기타)별 - 업계 동향 및 2031년까지의 전망.

중동 및 아프리카 동물 및 인간 백신 시장 분석 및 통찰력

전 세계적으로 감염성 질환 의 유행이 증가하고 있으며, 독감과 박테리아 감염성 질환이 급속도로 급증하고 있어 시장 성장을 촉진하고 있습니다. 주사 부위의 발적, 통증 또는 붓기와 같은 경미한 부작용에는 알레르기 반응이 포함될 수 있으며, 반응은 극히 드물며 시장 성장에 도전할 것으로 예상됩니다.

Data Bridge Market Research에 따르면 중동 및 아프리카 동물 및 인간 백신 시장은 2023년 3,480,103.50만 달러에서 2031년 5,358,452.80만 달러로 성장할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률 5.6%로 성장할 것으로 예상됩니다.

보고서 메트릭	세부
예측 기간	2024년부터 2031년까지
기준 연도	2023
역사적 연도	2022 (2016-2021년까지 사용자 정의 가능)
양적 단위	수익 (USD 천)
다루는 세그먼트	유형(인간 및 동물), 최종 사용자(병원, 진료소 및 기타), 유통 채널(직접 입찰, 소매 판매 및 기타)
적용 국가	사우디아라비아, 이집트, UAE, 이스라엘, 이란, 이라크, 오만, 쿠웨이트, 카타르, 바레인, 예멘, 요르단, 레바논, 팔레스타인, 기타 중동 지역, 남아프리카공화국, 나이지리아, 에티오피아, 탄자니아, 케냐, 알제리, 가나, 모잠비크 , 우간다, 콩고민주공화국, 수단, 모로코, 앙골라, 마다가스카르, 말라위, 잠비아, 코트디부아르, 카메룬, 짐바브웨, 리비아, 차드, 보츠와나, 나미비아, 레소토, 모리셔스, 에스와티니, 코모로, 세이셸 및 기타 아프리카 지역
시장 참여자 포함	GSK plc., Merck & Co., Inc., Sanofi, Boehringer Ingelheim International GmbH., Ceva, ONDERSTEPOORT BIOLOGICAL PRODUCTS SOC (PTY) LTD, MCI Santé Animale, Biogénesis Bagó 및 HESTER BIOSCIENCES LIMITED 등

시장 정의

백신은 특정 질병에 대한 면역을 유도하기 위해 개인의 면역 체계를 자극하는 제품입니다. 백신은 기억과 인식의 원리에 따라 작동합니다. 약화되거나 죽은 미생물을 신체에 주입하면 이러한 미생물은 면역 체계의 기억 세포인 B 세포가 병원체를 인식하게 하고, 미래에 동일한 병원체가 신체를 공격하면 해당 병원체에 대항합니다. 백신은 폐렴구균성 질환, 홍역, 이하선염, 풍진, 간염, 독감, 장티푸스, 수두, 광견병 등을 포함한 주변에 만연한 여러 종류의 감염성 질병에 대해 발견되었습니다.

중동 및 아프리카 동물 및 인간 백신 시장 동향

이 섹션에서는 시장 동인, 기회, 과제 및 제약을 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.

운전자

확대되는 예방접종 프로그램 및 캠페인

중동 및 아프리카 국가에서 강력한 예방 접종 프로그램을 시행하는 것은 공중 보건을 강화하고 전염병 확산을 예방하는 데 필수적입니다. 이러한 이니셔티브의 성공을 보장하려면 포괄적인 인식 캠페인을 실시하는 것이 중요합니다. 만성 질환의 수가 증가함에 따라 전 세계적으로 예방 접종 프로그램과 캠페인이 증가하고 있습니다. 간염, 디프테리아, 백일해, 소아마비 등의 전염병이 환경에 만연함에 따라 여러 캠페인과 프로그램을 시작하여 예방 접종에 대한 인식을 높이는 것이 시급히 필요합니다. 이는 예방 접종 프로그램의 수가 전염병의 증가와 함께 증가하고 있다는 보고가 있습니다. 이와 함께 전 세계적으로 면역 접종 범위도 증가하여 쇠약해지는 질병과 싸우고자 합니다.

만성 질환의 유병률 증가

전 세계적으로 감염병의 유행이 증가하고 있으며, 독감과 박테리아 감염병이 급속도로 급증하고 있는 것으로 나타났습니다. 이러한 감염병의 유행 속도로 인해 예방 접종이나 면역을 통해 예방할 수 있는 질병 예방에 대한 필요성이 생겨났습니다. 질병이 상당한 속도로 증가하고 있기 때문에 대량 예방 접종이 시급히 필요합니다. 대량 예방 접종에는 많은 양의 백신 질병이 필요하므로 시장에 수익성 있는 성장을 제공할 것으로 예상됩니다. 전 세계적으로 만성 질환이 증가함에 따라 백신 수요가 상당히 높아져 백신 시장이 확대되었습니다. 이러한 건강 문제가 심화됨에 따라 다양한 만성 질환의 발생률과 심각성을 줄이는 데 백신이 할 수 있는 예방적 역할에 대한 인식이 높아지고 있습니다.

기회

시장 참여자의 전략적 개시 및 결정

백신 시장에서 시장 참여자들은 확장, 협업, 인수 등을 포함한 다양한 전략적 이니셔티브를 채택합니다. 이러한 이니셔티브를 통해 회사의 제품 포트폴리오를 늘려 시장 확장으로 이어지고, 궁극적으로 고객 사이에서 제품 수요를 높여 시장 참여자들이 최대 수익을 얻을 수 있습니다. 한 가지 중요한 측면은 새로운 건강 위협을 해결하는 새로운 백신을 혁신하고 도입하기 위한 연구 개발에 대한 지속적인 투자입니다. 연구 기관, 정부 기관, 중동 및 아프리카 건강 기관과의 협업은 집단적 전문 지식과 리소스를 활용하는 데 도움이 됩니다.

이러한 전략적 이니셔티브는 전 세계적으로 효과적이고 새로운 백신에 대한 수요가 증가함에 따라 사업 운영을 개선하고 시장에서 더 많은 수익성을 얻기 위해 주요 시장 주자들이 취하는 것입니다.

제약/도전

시중에 등록된 백신이 부족함

백신에 대한 엄격한 규제 승인과 시간이 많이 걸리는 개발 절차는 등록된 백신을 구할 수 없는 몇 가지 요인입니다. 등록된 백신을 구할 수 없으면 공중 보건에 중대한 영향을 미쳐 질병 예방 및 통제에 어려움을 겪을 수 있습니다. 백신을 구할 수 없으면 감염병에 대한 취약성이 증가하고, 잠재적인 발병이 발생하며, 인구의 심각한 건강 문제가 발생할 위험이 높아질 수 있습니다. 등록된 백신을 구할 수 없는 문제를 해결하려면 규제 기관, 제약 회사, 의료 시스템의 노력이 결합되어야 합니다. 규제 당국은 백신의 평가, 허가, 통제 및 감시에 어려움을 겪습니다. 이러한 규제로 인해 백신의 세계 공급이 지연됩니다.

백신 접종으로 인한 유해한 부작용

백신은 의료 제품이며 다양한 질병을 예방하는 데 도움이 됩니다. 그러나 때로는 백신 사용으로 인해 부작용이 발생합니다. 그 중 일부는 주사 부위의 발적, 통증 또는 붓기와 같은 가벼운 부작용입니다. 대부분의 백신 부작용은 가볍고 일시적이며 심각한 질병을 예방하는 데 있어 백신 접종의 이점은 위험보다 훨씬 큽니다. 여기에는 알레르기 반응이 포함될 수 있지만 심각한 알레르기 반응은 극히 드뭅니다. 또한 모든 의학적 개입과 마찬가지로 백신은 길랭-바레 증후군(GBS)이나 혈전증과 같은 드물지만 심각한 부작용을 일으킬 수 있습니다. 그러나 백신의 부작용은 드물지만 생명을 위협합니다.

최근 개발 사항

2023년 1월, Boehringer Ingelheim의 최근 혁신 제품인 Senvelgo는 권위 있는 Animal Health Best New Product for Companion Animals 상을 수상했습니다. 이 상은 Senvelgo가 당뇨병 고양이의 치료를 간소화하고 개선하는 데 크게 기여한 공로를 인정한 것입니다. 혁신에 대한 Boehringer Ingelheim의 헌신은 Senvelgo에서 분명하게 드러납니다. 고양이 환자와 간병인 모두에게 간단하고 안전할 뿐만 아니라 매우 편리한 솔루션을 제공합니다.
2023년 Merck & Co., Inc.는 미국 식품의약국(FDA)으로부터 FIGO 2014 3기 IVA 자궁경부암 환자를 치료하기 위해 항PD-1 치료제인 KEYTRUDA를 화학방사선요법(CRT)과 병용한 것에 대한 승인을 받았습니다. 이 승인은 KEYTRUDA와 CRT를 병용한 3상 KEYNOTE-A18 시험의 긍정적인 결과에 따른 것입니다. 이 시험에서 KEYTRUDA와 CRT를 병용한 경우 위약과 CRT를 병용한 경우에 비해 질병 진행 또는 사망 위험이 41% 감소했습니다. 두 그룹 모두 중간 진행 무진행 생존율(PFS)에 도달하지 못했습니다. 이는 자궁경부암에서 KEYTRUDA의 세 번째 적응증을 나타내며, 그 효과를 강조하고 미국에서 KEYTRUDA의 39번째 전체 적응증입니다. 이 이정표는 다양한 유형의 암 환자를 위한 치료 옵션을 발전시키려는 Merck의 노력을 강조합니다.
2023년 7월, Biogenesis Bago는 유엔 식량 농업 기구(FAO) 산하에서 BIOAFTOGEN을 발표했습니다. 이는 BIOAFTOGEN이 이러한 사전 자격을 받은 최초의 구제역 백신이 되면서 역사적인 순간을 기념합니다. 이러한 성과는 구제역 예방 분야의 글로벌 리더로서의 회사의 입지를 강화하고, 선도적인 기술 및 과학 기관과의 협력에 대한 회사의 의지를 강화하여 전 세계적으로 식품 안전과 동물 건강 상태에 기여합니다.
2020년 11월, GSK plc.는 Medicines for Malaria Venture와 함께 어린이와 청소년의 플라스모디움 비박스 말라리아 치료에 사용되는 타페노퀸에 대한 긍정적인 데이터(TEACH 연구)를 발표했습니다. 4개월 동안의 검사 기간 동안, 연구에 참여한 60명의 피험자 중 95%가 플라스모디움 비박스 말라리아 증상을 보이지 않았습니다. 결과는 American Society of Tropical Medicine & Hygiene 2020의 가상 연례 회의를 통해 발표되었습니다. 이를 통해 회사는 말라리아 치료를 위한 제품을 개발하고 제품의 증거를 제공할 수 있었습니다.
2020년 11월, Sanofi는 18세 이상 성인의 인플루엔자 질병 예방을 위한 Supemtek(4가 재조합 인플루엔자 백신)에 대한 유럽 위원회의 승인을 받았습니다. 이 승인은 회사가 백신과 관련된 제품 포트폴리오를 발전시키고 유럽 백신 시장에서의 뿌리를 강화하는 데 도움이 되었습니다.

중동 및 아프리카 동물 및 인간 백신 시장 범위

중동 및 아프리카 동물 및 인간 백신 시장은 유형, 최종 사용자 및 유통 채널을 기준으로 세 가지 주요 세그먼트로 분류됩니다. 세그먼트 간 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.

유형

인간
동물

중동 및 아프리카 동물 및 인간 백신 시장은 유형을 기준으로 인간용과 동물용 백신으로 구분됩니다.

최종 사용자

병원
클리닉
기타

중동 및 아프리카의 동물 및 인간 백신 시장은 최종 사용자를 기준으로 병원, 진료소 및 기타로 구분됩니다.

유통 채널

직접 입찰
소매 판매
기타

중동 및 아프리카 동물 및 인간 백신 시장은 유통 경로를 기준으로 직접 입찰, 소매 판매 및 기타로 구분됩니다.

중동 및 아프리카 동물 및 인간 백신 시장 지역 분석/통찰력

중동 및 아프리카 동물 및 백신 시장은 유형, 최종 사용자, 유통 채널의 세 가지 주요 부문으로 분류됩니다.

이 시장 보고서에서 다루는 국가는 사우디 아라비아, 이집트, UAE, 이스라엘, 이란, 이라크, 오만, 쿠웨이트, 카타르, 바레인, 예멘, 요르단, 레바논, 팔레스타인, 기타 중동, 남아프리카, 나이지리아, 에티오피아, 탄자니아입니다. , 케냐, 알제리, 가나, 모잠비크, 우간다, 콩고민주공화국, 수단, 모로코, 앙골라, 마다가스카르, 말라위, 잠비아, 코트디부아르, 카메룬, 짐바브웨, 리비아, 차드, 보츠와나, 나미비아, 레소토, 모리셔스, 에스와티니, 코모로 , 세이셸 및 기타 아프리카 지역.

남아프리카 공화국은 정부 지원과 자금 지원이 증가함에 따라 아프리카 동물 및 백신 시장을 지배할 것으로 예상됩니다. 사우디 아라비아는 면역 프로그램과 캠페인이 확대됨에 따라 중동 동물 및 백신 시장을 지배할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 지역 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

중동 및 아프리카 동물 및 인간 백신 시장 경쟁 환경 및 점유율 분석

중동 및 아프리카 동물 및 인간 백신 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 승인, 제품 폭 및 호흡, 적용 우세, 제품 유형 수명선 곡선입니다. 위에 제공된 데이터 포인트는 중동 및 아프리카 동물 및 인간 백신 시장에 대한 회사의 초점과만 관련이 있습니다.

중동 및 아프리카 동물 및 인간 백신 시장의 주요 기업으로는 GSK plc., Merck & Co., Inc., Sanofi, Boehringer Ingelheim International GmbH., Ceva, ONDERSTEPOORT BIOLOGICAL PRODUCTS SOC (PTY) LTD, MCI Santé Animale, Biogénesis Bagó, HESTER BIOSCIENCES LIMITED 등이 있습니다.

SKU-70569

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Click on image to enlarge

대화형 데이터 분석 대시보드
높은 성장 잠재력 기회를 위한 회사 분석 대시보드
사용자 정의 및 질의를 위한 리서치 분석가 액세스
대화형 대시보드를 통한 경쟁자 분석
최신 뉴스, 업데이트 및 추세 분석
포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용

데모 요청

표 목록

TABLE 1 VACCINES UNDER CLINICAL TRIAL

TABLE 2 THE SIDE EFFECTS RELATED TO VACCINES

TABLE 3 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY TYPE 2022-2031 (USD THOUSAND)

TABLE 4 MIDDLE EAST AND AFRICA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 5 MIDDLE EAST AND AFRICA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 6 MIDDLE EAST AND AFRICA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 7 MIDDLE EAST AND AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 8 MIDDLE EAST AND AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 9 MIDDLE EAST AND AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 10 MIDDLE EAST AND AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

THE AFRICAN HORSE SICKNESS SEGMENT IS FURTHER SUB-SEGMENTED BY TYPE INTO LIVE AND INACTIVATED. 92

TABLE 11 MIDDLE EAST AND AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 12 MIDDLE EAST AND AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 13 MIDDLE EAST AND AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 14 MIDDLE EAST AND AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 15 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 16 MIDDLE EAST AND AFRICA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 17 MIDDLE EAST AND AFRICA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 18 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 19 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 20 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 21 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 22 MIDDLE EAST HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 23 MIDDLE EAST HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 24 MIDDLE EAST ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 25 MIDDLE EAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 26 MIDDLE EAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 27 MIDDLE EAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 28 MIDDLE EAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 29 MIDDLE EAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 30 MIDDLE EAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 31 MIDDLE EAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 32 MIDDLE EAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 33 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 34 MIDDLE EAST HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 35 MIDDLE EAST CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 36 MIDDLE EAST OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 37 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 38 SAUDI ARABIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 39 SAUDI ARABIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 40 SAUDI ARABIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 41 SAUDI ARABIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 42 SAUDI ARABIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 43 SAUDI ARABIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 44 SAUDI ARABIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 45 SAUDI ARABIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 46 SAUDI ARABIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 47 SAUDI ARABIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 48 SAUDI ARABIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 49 SAUDI ARABIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 50 SAUDI ARABIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 51 SAUDI ARABIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 52 SAUDI ARABIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 53 SAUDI ARABIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 54 SAUDI ARABIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 55 EGYPT ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 56 EGYPT HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 57 EGYPT HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 58 EGYPT ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 59 EGYPT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 60 EGYPT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 61 EGYPT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 62 EGYPT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 63 EGYPT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 64 EGYPT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 65 EGYPT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 66 EGYPT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 67 EGYPT ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 68 EGYPT HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 EGYPT CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 70 EGYPT OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 71 EGYPT ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 72 U.A.E. ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 73 U.A.E. HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 74 U.A.E. HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 75 U.A.E. ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 76 U.A.E. BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 77 U.A.E. BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 78 U.A.E. FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 79 U.A.E. FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 80 U.A.E. AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 81 U.A.E. AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 82 U.A.E. RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 83 U.A.E. RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 84 U.A.E. ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 85 U.A.E. HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 86 U.A.E. CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 87 U.A.E. OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 88 U.A.E. ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 89 ISRAEL ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 90 ISRAEL HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 91 ISRAEL HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 92 ISRAEL ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 93 ISRAEL BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 94 ISRAEL BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 95 ISRAEL FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 96 ISRAEL FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 97 ISRAEL AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 98 ISRAEL AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 99 ISRAEL RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 100 ISRAEL RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 101 ISRAEL ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 102 ISRAEL HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 103 ISRAEL CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 104 ISRAEL OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 105 ISRAEL ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 106 IRAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 107 IRAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 108 IRAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 109 IRAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 110 IRAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 111 IRAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 112 IRAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 113 IRAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 114 IRAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 115 IRAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 116 IRAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 117 IRAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 118 IRAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 119 IRAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 120 IRAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 121 IRAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 122 IRAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 123 IRAQ ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 124 IRAQ HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 125 IRAQ HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 126 IRAQ ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 127 IRAQ BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 128 IRAQ BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 129 IRAQ FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 130 IRAQ FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 131 IRAQ AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 132 IRAQ AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 133 IRAQ RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 134 IRAQ RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 135 IRAQ ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 136 IRAQ HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 137 IRAQ CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 138 IRAQ OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 139 IRAQ ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 140 OMAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 141 OMAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 142 OMAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 143 OMAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 144 OMAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 145 OMAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 146 OMAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 147 OMAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 148 OMAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 149 OMAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 150 OMAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 151 OMAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 152 OMAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 153 OMAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 154 OMAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 155 OMAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 156 OMAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 157 KUWAIT ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 158 KUWAIT HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 159 KUWAIT HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 160 KUWAIT ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 161 KUWAIT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 162 KUWAIT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 163 KUWAIT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 164 KUWAIT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 165 KUWAIT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 166 KUWAIT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 167 KUWAIT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 168 KUWAIT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 169 KUWAIT ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 170 KUWAIT HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 171 KUWAIT CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 172 KUWAIT OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 173 KUWAIT ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 174 QATAR ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 175 QATAR HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 176 QATAR HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 177 QATAR ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 178 QATAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 179 QATAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 180 QATAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 181 QATAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 182 QATAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 183 QATAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 184 QATAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 185 QATAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 186 QATAR ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 187 QATAR HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 188 QATAR CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 189 QATAR OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 190 QATAR ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 191 BAHRAIN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 192 BAHRAIN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 193 BAHRAIN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 194 BAHRAIN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 195 BAHRAIN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 196 BAHRAIN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 197 BAHRAIN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 198 BAHRAIN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 199 BAHRAIN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 200 BAHRAIN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 201 BAHRAIN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 202 BAHRAIN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 203 BAHRAIN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 204 BAHRAIN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 205 BAHRAIN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 206 BAHRAIN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 207 BAHRAIN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 208 YEMEN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 209 YEMEN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 210 YEMEN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 211 YEMEN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 212 YEMEN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 213 YEMEN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 214 YEMEN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 215 YEMEN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 216 YEMEN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 217 YEMEN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 218 YEMEN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 219 YEMEN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 220 YEMEN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 221 YEMEN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 222 YEMEN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 223 YEMEN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 224 YEMEN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 225 JORDAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 226 JORDAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 227 JORDAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 228 JORDAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 229 JORDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 230 JORDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 231 JORDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 232 JORDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 233 JORDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 234 JORDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 235 JORDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 236 JORDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 237 JORDAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 238 JORDAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 239 JORDAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 240 JORDAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 241 JORDAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 242 LEBANON ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 243 LEBANON HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 244 LEBANON HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 245 LEBANON ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 246 LEBANON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 247 LEBANON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 248 LEBANON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 249 LEBANON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 250 LEBANON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 251 LEBANON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 252 LEBANON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 253 LEBANON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 254 LEBANON ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 255 LEBANON HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 256 LEBANON CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 257 LEBANON OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 258 LEBANON ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 259 PALESTINE ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 260 PALESTINE HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 261 PALESTINE HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 262 PALESTINE ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 263 PALESTINE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 264 PALESTINE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 265 PALESTINE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 266 PALESTINE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 267 PALESTINE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 268 PALESTINE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 269 PALESTINE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 270 PALESTINE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 271 PALESTINE ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 272 PALESTINE HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 273 PALESTINE CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 274 PALESTINE OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 275 PALESTINE ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 276 REST OF MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 277 AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 278 AFRICA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 279 AFRICA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 280 AFRICA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 281 AFRICA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 282 AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 283 AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 284 AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 285 AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 286 AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 287 AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 288 AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 289 AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 290 AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 291 AFRICA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 292 AFRICA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 293 AFRICA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 294 AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 295 SOUTH AFRICA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 296 SOUTH AFRICA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 297 SOUTH AFRICA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 298 SOUTH AFRICA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 299 SOUTH AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 300 SOUTH AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 301 SOUTH AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 302 SOUTH AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 303 SOUTH AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 304 SOUTH AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 305 SOUTH AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 306 SOUTH AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 307 SOUTH AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 308 SOUTH AFRICA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 309 SOUTH AFRICA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 310 SOUTH AFRICA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 311 SOUTH AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 312 NIGERIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 313 NIGERIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 314 NIGERIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 315 NIGERIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 316 NIGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 317 NIGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 318 NIGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 319 NIGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 320 NIGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 321 NIGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 322 NIGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 323 NIGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 324 NIGERIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 325 NIGERIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 326 NIGERIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 327 NIGERIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 328 NIGERIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 329 ETHIOPIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 330 ETHIOPIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 331 ETHIOPIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 332 ETHIOPIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 333 ETHIOPIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 334 ETHIOPIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 335 ETHIOPIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 336 ETHIOPIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 337 ETHIOPIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 338 ETHIOPIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 339 ETHIOPIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 340 ETHIOPIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 341 ETHIOPIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 342 ETHIOPIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 343 ETHIOPIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 344 ETHIOPIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 345 ETHIOPIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 346 TANZANIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 347 TANZANIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 348 TANZANIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 349 TANZANIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 350 TANZANIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 351 TANZANIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 352 TANZANIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 353 TANZANIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 354 TANZANIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 355 TANZANIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 356 TANZANIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 357 TANZANIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 358 TANZANIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 359 TANZANIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 360 TANZANIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 361 TANZANIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 362 TANZANIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 363 KENYA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 364 KENYA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 365 KENYA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 366 KENYA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 367 KENYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 368 KENYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 369 KENYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 370 KENYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 371 KENYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 372 KENYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 373 KENYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 374 KENYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 375 KENYA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 376 KENYA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 377 KENYA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 378 KENYA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 379 KENYA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 380 ALGERIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 381 ALGERIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 382 ALGERIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 383 ALGERIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 384 ALGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 385 ALGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 386 ALGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 387 ALGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 388 ALGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 389 ALGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 390 ALGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 391 ALGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 392 ALGERIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 393 ALGERIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 394 ALGERIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 395 ALGERIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 396 ALGERIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 397 GHANA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 398 GHANA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 399 GHANA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 400 GHANA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 401 GHANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 402 GHANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 403 GHANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 404 GHANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 405 GHANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 406 GHANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 407 GHANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 408 GHANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 409 GHANA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 410 GHANA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 411 GHANA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 412 GHANA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 413 GHANA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 414 MOZAMBIQUE ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 415 MOZAMBIQUE HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 416 MOZAMBIQUE HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 417 MOZAMBIQUE ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 418 MOZAMBIQUE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 419 MOZAMBIQUE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 420 MOZAMBIQUE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 421 MOZAMBIQUE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 422 MOZAMBIQUE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 423 MOZAMBIQUE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 424 MOZAMBIQUE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 425 MOZAMBIQUE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 426 MOZAMBIQUE ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 427 MOZAMBIQUE HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 428 MOZAMBIQUE CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 429 MOZAMBIQUE OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 430 MOZAMBIQUE ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 431 UGANDA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 432 UGANDA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 433 UGANDA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 434 UGANDA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 435 UGANDA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 436 UGANDA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 437 UGANDA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 438 UGANDA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 439 UGANDA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 440 UGANDA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 441 UGANDA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 442 UGANDA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 443 UGANDA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 444 UGANDA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 445 UGANDA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 446 UGANDA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 447 UGANDA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 448 DEMOCRATIC REPUBLIC OF CONGO ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 449 DEMOCRATIC REPUBLIC OF CONGO HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 450 DEMOCRATIC REPUBLIC OF CONGO HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 451 DEMOCRATIC REPUBLIC OF CONGO ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 452 DEMOCRATIC REPUBLIC OF CONGO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 453 DEMOCRATIC REPUBLIC OF CONGO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 454 DEMOCRATIC REPUBLIC OF CONGO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 455 DEMOCRATIC REPUBLIC OF CONGO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 456 DEMOCRATIC REPUBLIC OF CONGO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 457 DEMOCRATIC REPUBLIC OF CONGO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 458 DEMOCRATIC REPUBLIC OF CONGO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 459 DEMOCRATIC REPUBLIC OF CONGO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 460 DEMOCRATIC REPUBLIC OF CONGO ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 461 DEMOCRATIC REPUBLIC OF CONGO HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 462 DEMOCRATIC REPUBLIC OF CONGO CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 463 DEMOCRATIC REPUBLIC OF CONGO OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 464 DEMOCRATIC REPUBLIC OF CONGO ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 465 SUDAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 466 SUDAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 467 SUDAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 468 SUDAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 469 SUDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 470 SUDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 471 SUDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 472 SUDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 473 SUDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 474 SUDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 475 SUDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 476 SUDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 477 SUDAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 478 SUDAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 479 SUDAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 480 SUDAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 481 SUDAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 482 MOROCCO ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 483 MOROCCO HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 484 MOROCCO HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 485 MOROCCO ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 486 MOROCCO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 487 MOROCCO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 488 MOROCCO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 489 MOROCCO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 490 MOROCCO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 491 MOROCCO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 492 MOROCCO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 493 MOROCCO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 494 MOROCCO ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 495 MOROCCO HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 496 MOROCCO CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 497 MOROCCO OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 498 MOROCCO ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 499 ANGOLA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 500 ANGOLA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 501 ANGOLA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 502 ANGOLA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 503 ANGOLA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 504 ANGOLA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 505 ANGOLA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 506 ANGOLA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 507 ANGOLA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 508 ANGOLA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 509 ANGOLA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 510 ANGOLA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 511 ANGOLA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 512 ANGOLA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 513 ANGOLA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 514 ANGOLA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 515 ANGOLA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 516 MADAGASCAR ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 517 MADAGASCAR HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 518 MADAGASCAR HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 519 MADAGASCAR ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 520 MADAGASCAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 521 MADAGASCAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 522 MADAGASCAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 523 MADAGASCAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 524 MADAGASCAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 525 MADAGASCAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 526 MADAGASCAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 527 MADAGASCAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 528 MADAGASCAR ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 529 MADAGASCAR HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 530 MADAGASCAR CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 531 MADAGASCAR OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 532 MADAGASCAR ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 533 MALAWI ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 534 MALAWI HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 535 MALAWI HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 536 MALAWI ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 537 MALAWI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 538 MALAWI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 539 MALAWI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 540 MALAWI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 541 MALAWI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 542 MALAWI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 543 MALAWI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 544 MALAWI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 545 MALAWI ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 546 MALAWI HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 547 MALAWI CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 548 MALAWI OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 549 MALAWI ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 550 ZAMBIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 551 ZAMBIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 552 ZAMBIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 553 ZAMBIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 554 ZAMBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 555 ZAMBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 556 ZAMBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 557 ZAMBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 558 ZAMBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 559 ZAMBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 560 ZAMBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 561 ZAMBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 562 ZAMBIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 563 ZAMBIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 564 ZAMBIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 565 ZAMBIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 566 ZAMBIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 567 IVORY COAST ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 568 IVORY COAST HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 569 IVORY COAST HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 570 IVORY COAST ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 571 IVORY COAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 572 IVORY COAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 573 IVORY COAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 574 IVORY COAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 575 IVORY COAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 576 IVORY COAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 577 IVORY COAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 578 IVORY COAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 579 IVORY COAST ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 580 IVORY COAST HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 581 IVORY COAST CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 582 IVORY COAST OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 583 IVORY COAST ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 584 CAMEROON ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 585 CAMEROON HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 586 CAMEROON HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 587 CAMEROON ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 588 CAMEROON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 589 CAMEROON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 590 CAMEROON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 591 CAMEROON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 592 CAMEROON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 593 CAMEROON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 594 CAMEROON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 595 CAMEROON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 596 CAMEROON ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 597 CAMEROON HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 598 CAMEROON CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 599 CAMEROON OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 600 CAMEROON ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 601 ZIMBABWE ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 602 ZIMBABWE HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 603 ZIMBABWE HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 604 ZIMBABWE ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 605 ZIMBABWE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 606 ZIMBABWE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 607 ZIMBABWE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 608 ZIMBABWE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 609 ZIMBABWE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 610 ZIMBABWE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 611 ZIMBABWE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 612 ZIMBABWE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 613 ZIMBABWE ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 614 ZIMBABWE HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 615 ZIMBABWE CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 616 ZIMBABWE OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 617 ZIMBABWE ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 618 LIBYA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 619 LIBYA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 620 LIBYA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 621 LIBYA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 622 LIBYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 623 LIBYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 624 LIBYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 625 LIBYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 626 LIBYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 627 LIBYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 628 LIBYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 629 LIBYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 630 LIBYA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 631 LIBYA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 632 LIBYA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 633 LIBYA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 634 LIBYA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 635 CHAD ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 636 CHAD HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 637 CHAD HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 638 CHAD ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 639 CHAD BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 640 CHAD BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 641 CHAD FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 642 CHAD FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 643 CHAD AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 644 CHAD AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 645 CHAD RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 646 CHAD RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 647 CHAD ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 648 CHAD HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 649 CHAD CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 650 CHAD OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 651 CHAD ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 652 BOTSWANA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 653 BOTSWANA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 654 BOTSWANA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 655 BOTSWANA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 656 BOTSWANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 657 BOTSWANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 658 BOTSWANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 659 BOTSWANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 660 BOTSWANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 661 BOTSWANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 662 BOTSWANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 663 BOTSWANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 664 BOTSWANA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 665 BOTSWANA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 666 BOTSWANA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 667 BOTSWANA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 668 BOTSWANA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 669 NAMIBIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 670 NAMIBIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 671 NAMIBIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 672 NAMIBIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 673 NAMIBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 674 NAMIBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 675 NAMIBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 676 NAMIBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 677 NAMIBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 678 NAMIBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 679 NAMIBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 680 NAMIBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 681 NAMIBIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 682 NAMIBIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 683 NAMIBIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 684 NAMIBIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 685 NAMIBIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 686 LESOTHO ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 687 LESOTHO HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 688 LESOTHO HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 689 LESOTHO ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 690 LESOTHO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 691 LESOTHO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 692 LESOTHO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 693 LESOTHO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 694 LESOTHO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 695 LESOTHO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 696 LESOTHO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 697 LESOTHO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 698 LESOTHO ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 699 LESOTHO HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 700 LESOTHO CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 701 LESOTHO OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 702 LESOTHO ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 703 MAURITIUS ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 704 MAURITIUS HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 705 MAURITIUS HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 706 MAURITIUS ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 707 MAURITIUS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 708 MAURITIUS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 709 MAURITIUS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 710 MAURITIUS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 711 MAURITIUS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 712 MAURITIUS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 713 MAURITIUS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 714 MAURITIUS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 715 MAURITIUS ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 716 MAURITIUS HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 717 MAURITIUS CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 718 MAURITIUS OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 719 MAURITIUS ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 720 ESWATINI ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 721 ESWATINI HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 722 ESWATINI HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 723 ESWATINI ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 724 ESWATINI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 725 ESWATINI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 726 ESWATINI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 727 ESWATINI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 728 ESWATINI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 729 ESWATINI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 730 ESWATINI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 731 ESWATINI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 732 ESWATINI ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 733 ESWATINI HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 734 ESWATINI CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 735 ESWATINI OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 736 ESWATINI ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 737 COMOROS ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 738 COMOROS HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 739 COMOROS HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 740 COMOROS ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 741 COMOROS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 742 COMOROS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 743 COMOROS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 744 COMOROS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 745 COMOROS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 746 COMOROS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 747 COMOROS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 748 COMOROS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 749 COMOROS ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 750 COMOROS HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 751 COMOROS CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 752 COMOROS OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 753 COMOROS ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 754 SEYCHELLES ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

TABLE 755 SEYCHELLES HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 756 SEYCHELLES HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)

TABLE 757 SEYCHELLES ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 758 SEYCHELLES BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 759 SEYCHELLES BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 760 SEYCHELLES FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 761 SEYCHELLES FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 762 SEYCHELLES AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 763 SEYCHELLES AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)

TABLE 764 SEYCHELLES RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 765 SEYCHELLES RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)

TABLE 766 SEYCHELLES ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 767 SEYCHELLES HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 768 SEYCHELLES CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 769 SEYCHELLES OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 770 SEYCHELLES ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 771 REST OF AFRICA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)

그림 목록

FIGURE 1 INDIA AND EUROPE GENERIC INJECTABLES MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: SEGMENTATION

FIGURE 10 ESCALATING INCIDENCE OF CHRONIC DISEASES AND SURGE IN THE DEVELOPMENT AND PRODUCTION OF VACCINES ARE DRIVING THE GROWTH OF THE MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET IN THE FORECAST PERIOD OF 2024 TO 2031

FIGURE 11 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET IN 2024 AND 2031

FIGURE 12 OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET

FIGURE 13 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY TYPE, 2023

FIGURE 14 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY TYPE, 2024-2031 (USD THOUSAND)

FIGURE 15 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY TYPE, CAGR (2024-2031)

FIGURE 16 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY TYPE, LIFELINE CURVE

FIGURE 17 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY END USER, 2023

FIGURE 18 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY END USER, 2024-2031 (USD THOUSAND)

FIGURE 19 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY END USER, CAGR (2024-2031)

FIGURE 20 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY END USER, LIFELINE CURVE

FIGURE 21 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 22 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)

FIGURE 23 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 24 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 25 MIDDLE EAST &AFRICA ANIMAL AND HUMAN VACCINES MARKET: SNAPSHOT (2023)

FIGURE 26 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET: SNAPSHOT (2023)

FIGURE 27 AFRICA ANIMAL AND HUMAN VACCINES MARKET: SNAPSHOT (2023)

FIGURE 28 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: COMPANY SHARE 2023 (%)

자세한 정보 보기

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

How big is the Middle East and Africa animal and human vaccines market?

The Middle East and Africa animal and human vaccines market size will be worth USD 5,358,452.80 thousand by 2031.

What is the growth rate of the Middle East and Africa animal and human vaccines market?

The growth rate of the Middle East and Africa animal and human vaccines market is 5.6%.

What are the latest developments in the Middle East and Africa animal and human vaccines market?

The latest developments in the Middle East and Africa animal and human vaccines market are - In January 2023, Senvelgo, the recent innovation from Boehringer Ingelheim, has secured the prestigious Animal Health Best New Product for Companion Animals award & Merck & Co., Inc. received approval from the U.S. Food and Drug Administration (FDA) for KEYTRUDA, its anti-PD-1 therapy, in combination with chemoradiotherapy (CRT) for treating patients with FIGO 2014 Stage III-IVA cervical cancer.

What are the factors on which the Middle East and Africa animal and human vaccines market research is based on?

Type, end user, and distribution channel are the factors on which the Middle East and Africa animal and human vaccines market research is based.

What are the growth drivers of the Middle East and Africa animal and human vaccines market?

Growing immunization programs and campaigns & growing prevalence of chronic conditions are the growth drivers of the Middle East and Africa animal and human vaccines market.

중동 및 아프리카 동물 및 인간 백신 시장 – 2031년까지의 산업 동향 및 예측

중동 및 아프리카 동물 및 인간 백신 시장 – 2031년까지의 산업 동향 및 예측

중동 및 아프리카 동물 및 인간 백신 시장 분석 및 통찰력

중동 및 아프리카 동물 및 인간 백신 시장 동향

중동 및 아프리카 동물 및 인간 백신 시장 범위

중동 및 아프리카 동물 및 인간 백신 시장 지역 분석/통찰력

중동 및 아프리카 동물 및 인간 백신 시장 경쟁 환경 및 점유율 분석

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

목차

표 목록

그림 목록

연구 방법론

사용자 정의 가능

자주 묻는 질문

보고서

시장 통찰력

지원하다

솔루션

중동 및 아프리카 동물 및 인간 백신 시장 – 2031년까지의 산업 동향 및 예측

중동 및 아프리카 동물 및 인간 백신 시장 – 2031년까지의 산업 동향 및 예측

중동 및 아프리카 동물 및 인간 백신 시장 분석 및 통찰력

중동 및 아프리카 동물 및 인간 백신 시장 동향

중동 및 아프리카 동물 및 인간 백신 시장 범위

중동 및 아프리카 동물 및 인간 백신 시장 지역 분석/통찰력

중동 및 아프리카 동물 및 인간 백신 시장 경쟁 환경 및 점유율 분석

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

목차

표 목록

그림 목록

연구 방법론

사용자 정의 가능

자주 묻는 질문

관련 페이지 탐색